Filing Flows › Aktis Oncology (AKTS) › How it makes money
How Aktis Oncology (AKTS) makes money
Aktis Oncology (AKTS) made $3.4M of revenue in the second quarter 2026 (Q2 2026), +111% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $3.4M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $3.4M | +111% |
| Q1 2026 | $3.2M | +123% |
From Aktis Oncology's 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Aktis Oncology make money?
Aktis Oncology (AKTS) made $3.4M of revenue in the second quarter 2026 (Q2 2026), +111% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.